Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolic Acid in Acute Ischemic Stroke
NCT04931628Terminated
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Feb 2023
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in ischemic stroke comparing Salvianolic Acid Group with Placebo Group (2 arms). Primary endpoint: modified Rankin Scale at 90 days. Started Feb 2023; status: terminated.
02
Drugs
danshen polyphenolic acid
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04931628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04931628.